 |
市場調查報告書
商品編碼
1321789
數字 PCR (dPCR) 和實時 PCR (qPCR) 的全球市場 - 市場規模、份額、增長分析：按產品、技術、應用、最終用戶 - 行業預測 (2023-2030)Global Digital PCR and Real-time PCR Market Size, Share, Growth Analysis, By Product, By Technology(Digital PCR, and quantitative PCR ), By Application, By End-user - Industry Forecast 2023-2030 |
||||||
全球數字 PCR (dPCR)/實時 PCR (qPCR) 市場規模將從 2022 年的 58,064.8 億美元增至 2030 年的 121,888.8 億美元，並且在預測期內（2023 年）將持續增長。預計2019年至2030年復合年增長率為8.8%。
遺傳性疾病和傳染病的流行、PCR、法醫學和其他實驗室的技術進步正在推動市場增長。 然而，與 PCR 相關的技術限制和使用替代檢測方法進行疾病檢測可能會阻礙市場增長。
促進因素
在各種傳染病的流行、遺傳疾病數量的增加以及人類基因組計劃的成功的推動下，預計該市場將在預測期內顯著增長。 數字 PCR 和實時 PCR 是強大的分子生物學技術，可用於檢測和定量核酸（細胞的遺傳物質）。 這些技術具有廣泛的應用，包括臨床診斷、研究和法醫學。 傳染病爆發是市場的主要驅動因素。 這些疾病包括艾滋病毒/艾滋病、瘧疾、肺結核和流感。 數字PCR和實時PCR可以快速準確地檢測這些疾病，這對於早期診斷和治療至關重要。 遺傳疾病的增加是市場的另一個主要驅動力。 這些疾病包括囊性纖維化、鐮狀細胞病和泰薩克斯病。 數字PCR和實時PCR可用於診斷這些疾病並跟蹤治療效果。 人類基因組計劃的成功也導致了對數字PCR和實時PCR的需求增加。 人類基因組計劃提供了大量有關人類遺傳學的信息，可用於開發數字 PCR 和實時 PCR 的新診斷和治療應用。
抑制因素
dPCR/qPCR 的技術限制，例如需要在 PCR 反應的指數階段進行信號測量以及需要優化和驗證檢測程序，可能會阻礙市場增長。 這些限制可能會由於反應抑製或無法測試目標分子而導致目標檢測失敗。
主要市場趨勢
隨著病毒感染患者數量的增加，用於發現這些疾病的治療藥物和生物標誌物的數字 PCR 技術的發展正在取得進展。 數字 PCR 技術也得到了改進，可以檢測罕見的癌症生物標誌物。 研究人員可以將數字液滴 PCR (ddPCR) 與分子生物學技術結合使用來識別新的癌症生物標誌物。
本報告研究和分析了全球數字PCR（dPCR）和實時PCR（qPCR）市場，提供市場動態和前景、細分分析、公司簡介等。
目錄
執行摘要
調查方法
母公司市場分析
- 市場概覽
- 市場規模
- 市場動態
- 促進因素
- 機會
- 抑制因素
- 作業
主要市場考慮因素
- 技術分析
- 價格分析
- 供應鏈分析
- 價值鏈分析
- 市場生態系統
- 知識產權分析
- 貿易分析
- 啟動分析
- 原材料分析
- 創新矩陣
- 管道產品分析
- 宏觀經濟指標
- 主要投資分析
- 關鍵成功因素
- 競爭程度
市場動態與展望
- 市場動態
- 促進因素
- 機會
- 抑制因素
- 作業
- 監管情況
- 波特的分析
- 對未來中斷的特殊考慮
全球數字 PCR (dPCR)/實時 PCR (qPCR) 市場：按產品劃分
- 市場概覽
- 試劑/消耗品
- 設備
- 軟件
全球數字 PCR (dPCR)/實時 PCR (qPCR) 市場：按技術劃分
- 市場概覽
- 數字 PCR (dPCR)
- 定量 PCR (qPCR)
全球數字 PCR (dPCR)/實時 PCR (qPCR) 市場：按應用劃分
- 市場概覽
- 研究用途
- 臨床應用
- 取證應用
全球數字 PCR (dPCR)/實時 PCR (qPCR) 市場：按最終用戶劃分
- 市場概覽
- 醫院/診斷中心
- 研究機構/學術機構
- 臨床研究所
- 其他
按地區劃分的全球數字 PCR (dPCR)/實時 PCR (qPCR) 市場規模
- 市場概覽
- 北美
- 美國
- 加拿大
- 歐洲
- 德國
- 西班牙
- 法國
- 英國
- 歐洲其他地區
- 亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太地區其他地區
- 拉丁美洲
- 巴西
- 其他拉丁美洲地區
- 中東/非洲
- 海灣合作委員會國家
- 南非
- 其他中東/非洲
競爭格局
- 排名前 5 名的公司比較
- 主要公司的市場定位（2021 年）
- 主要市場參與者採取的策略
- 關鍵成功策略
- 近期市場活動
- 主要公司的市場份額（2021 年）
主要公司簡介
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories, Inc.
- QIAGEN NV
- F. Hoffmann-La Roche Ltd.
- Agilent Technologies, Inc.
- Fluidigm Corporation
- Merck KGaA
- Takara Bio Inc.
- Illumina, Inc.
- Promega Corporation
- Abbott Laboratories
- Danaher Corporation
- Becton, Dickinson and Company
- GE Healthcare Life Sciences
- Eppendorf AG
- Analytik Jena AG
- Enzo Biochem, Inc.
- Luminex Corporation
- BioFire Diagnostics, Inc.
- Oxford Nanopore Technologies Ltd.
Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market size was valued at USD 5341.6 billion in 2021 and is poised to grow from USD 5806.48 billion in 2022 to USD 12018.88 billion by 2030, growing at a CAGR of 8.8% in the forecast period (2023-2030)
Real-time PCR and digital PCR are two widely used techniques for detecting and quantifying nucleic acids. Real-time PCR is a well-established technology that is known for its rapid and sensitive detection of nucleic acids in biological samples. Digital PCR, on the other hand, provides an absolute measure of target nucleic acid molecules by partitioning each sample into thousands of individual reactions.
The increasing prevalence of genetic and infectious diseases, as well as technological advancements in PCR, forensic, and other research laboratories, are driving the growth of the dPCR and qPCR market. However, technical limitations associated with PCR and the use of alternative assays to detect diseases may hinder market growth..
Segments covered in this report:
The Global digital PCR (dPCR) and real-time PCR (qPCR) market is segmented based on the product, technology, application, end-user, and region. Based on product, global digital PCR (dPCR) and real-time PCR (qPCR) market is segmented into reagents and consumables, instruments, and software. Based on technology, the digital PCR (dPCR) and real-time PCR (qPCR) market is segmented into digital PCR (dPCR), and quantitative PCR (qPCR). Based on application, the digital PCR (dPCR) and real-time PCR (qPCR) market is bifurcated into research applications, clinical applications, and forensic applications. Based on end-user, the digital PCR (dPCR) and real-time PCR (qPCR) market is bifurcated as hospitals & diagnostic centers, research laboratories & academic institutes, clinical research organizations, and others. Based on region, it is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.
Driver
The global digital PCR (dPCR) and real-time PCR (qPCR) market is expected to grow significantly during the forecast period, driven by the widespread prevalence of various infections, increasing genetic disorders, and the successful completion of the Human Genome Project. Digital PCR and real-time PCR are powerful molecular biology techniques that can be used to detect and quantify nucleic acids, the genetic material of cells. These techniques are used in a wide range of applications, including clinical diagnostics, research, and forensics. The increasing prevalence of infectious diseases is a major driver of the dPCR and qPCR market. These diseases include HIV/AIDS, malaria, tuberculosis, and influenza. Digital PCR and real-time PCR can be used to rapidly and accurately detect these diseases, which is essential for early diagnosis and treatment. Increasing genetic disorders is another major driver of the dPCR and qPCR market. These disorders include cystic fibrosis, sickle cell anemia, and Tay-Sachs disease. Digital PCR and real-time PCR can be used to diagnose these disorders, as well as to track the effectiveness of treatments. The successful completion of the Human Genome Project has also led to increased demand for digital PCR and real-time PCR. The Human Genome Project has provided a wealth of information about human genetics, which can be used to develop new diagnostic and therapeutic applications for digital PCR and real-time PCR.
Restraint
The technical limitations of dPCR and qPCR techniques, such as the need for signal measurement during the exponential phase of the PCR reaction and the optimization and validation of assay procedures, may hinder market growth. These limitations could lead to target detection failures due to reaction constraints or the inability to examine target molecules.
Key Market Trend
The increasing number of patients with viral infections has led to the development of digital PCR techniques to discover drugs or biomarkers for these diseases. Digital PCR techniques have also been improved to detect rare cancer biomarkers. Researchers can use digital droplet PCR (ddPCR) along with molecular biology techniques to identify new cancer biomarkers.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product
- Market Overview
- Reagents and consumables
- instruments
- and software
Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Technology
- Market Overview
- Digital PCR (dPCR)
- and quantitative PCR (qPCR)
Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Application
- Market Overview
- Research applications
- clinical applications
- and forensic applications
Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market by End-user
- Market Overview
- Hospitals & diagnostic centers
- research laboratories & academic institutes
- clinical research organizations
- and others
Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- QIAGEN N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- F. Hoffmann-La Roche Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Agilent Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Fluidigm Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Takara Bio Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Illumina, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Promega Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Becton, Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GE Healthcare Life Sciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eppendorf AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Analytik Jena AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Enzo Biochem, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Luminex Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BioFire Diagnostics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Oxford Nanopore Technologies Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
數位 PCR 市場：按產品類型、技術、應用和最終用戶分類 - 2024-2030 年全球預測
2024-2032 年按產品類型、技術、應用和地區分類的數位 PCR 市場報告
全球數位 PCR 市場規模、佔有率、成長分析，依技術（液滴數位 PCR 和基於晶片的數位 PCR）、產品類型、應用 - 產業預測 2024-2031
即時PCR、數位 PCR、端點 PCR 2024 年全球市場報告
全球即時 PCR、數位 PCR 和終點 PCR 市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測
即時 PCR (qPCR)、終點 PCR 和 dPCR 市場規模、佔有率和趨勢分析報告：按技術、按產品、按應用、按地區和細分趨勢：2024-2030 年
數位 PCR 和定量 PCR 市場 - 2023-2031 年全球產業分析、規模、佔有率、成長、趨勢和預測
即時 PCR 和數位PCR 的全球市場：趨勢、預測和競爭分析（截至 2030 年）
即時 PCR、數位 PCR 和終點 PCR 市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按技術、產品、按應用、地區、競爭預測和機會細分，2018 年-2028F
數位PCR市場 - 2018-2028F全球行業規模、佔有率、趨勢、機會和預測，按類型、按組件、按應用、按終端用戶、按區域和競爭情況分類